These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17822368)

  • 1. Homocysteine and glutathione peroxidase-1.
    Lubos E; Loscalzo J; Handy DE
    Antioxid Redox Signal; 2007 Nov; 9(11):1923-40. PubMed ID: 17822368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia.
    Weiss N; Keller C; Hoffmann U; Loscalzo J
    Vasc Med; 2002 Aug; 7(3):227-39. PubMed ID: 12553746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of vascular disease in hyperhomocysteinaemia.
    Domagała TB; Undas A; Libura M; Szczeklik A
    J Cardiovasc Risk; 1998 Aug; 5(4):239-47. PubMed ID: 9919472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase.
    Upchurch GR; Welch GN; Fabian AJ; Freedman JE; Johnson JL; Keaney JF; Loscalzo J
    J Biol Chem; 1997 Jul; 272(27):17012-7. PubMed ID: 9202015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction.
    Weiss N; Zhang YY; Heydrick S; Bierl C; Loscalzo J
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12503-8. PubMed ID: 11606774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling.
    Yan TT; Li Q; Zhang XH; Wu WK; Sun J; Li L; Zhang Q; Tan HM
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1071-7. PubMed ID: 20698860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Hyperhomocysteinemia and Hyperuricemia in Pathogenesis of Atherosclerosis.
    Zhao J; Chen H; Liu N; Chen J; Gu Y; Chen J; Yang K
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2695-2699. PubMed ID: 28986198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine and arterial thrombosis: Challenge and opportunity.
    Di Minno MN; Tremoli E; Coppola A; Lupoli R; Di Minno G
    Thromb Haemost; 2010 May; 103(5):942-61. PubMed ID: 20352150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium.
    Stanger O; Weger M
    Clin Chem Lab Med; 2003 Nov; 41(11):1444-54. PubMed ID: 14656024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of hyperhomocysteinemia on the cellular redox state--impact on homocysteine-induced endothelial dysfunction.
    Weiss N; Heydrick SJ; Postea O; Keller C; Keaney JF; Loscalzo J
    Clin Chem Lab Med; 2003 Nov; 41(11):1455-61. PubMed ID: 14656025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine and thrombosis: from basic science to clinical evidence.
    Undas A; Brozek J; Szczeklik A
    Thromb Haemost; 2005 Nov; 94(5):907-15. PubMed ID: 16363230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine-Induced Endothelial Dysfunction.
    Lai WK; Kan MY
    Ann Nutr Metab; 2015; 67(1):1-12. PubMed ID: 26201664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular oxidant stress and inflammation in hyperhomocysteinemia.
    Papatheodorou L; Weiss N
    Antioxid Redox Signal; 2007 Nov; 9(11):1941-58. PubMed ID: 17822365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels.
    Riba R; Nicolaou A; Troxler M; Homer-Vaniasinkam S; Naseem KM
    Atherosclerosis; 2004 Jul; 175(1):69-75. PubMed ID: 15186948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction.
    van Guldener C; Stehouwer CD
    Semin Thromb Hemost; 2000; 26(3):281-9. PubMed ID: 11011845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models.
    Wilson KM; Lentz SR
    Semin Vasc Med; 2005 May; 5(2):163-71. PubMed ID: 16047268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hyperhomocysteinemia decreases NO bioavailability in healthy adults.
    Romerio SC; Linder L; Nyfeler J; Wenk M; Litynsky P; Asmis R; Haefeli WE
    Atherosclerosis; 2004 Oct; 176(2):337-44. PubMed ID: 15380457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice.
    Weiss N; Heydrick S; Zhang YY; Bierl C; Cap A; Loscalzo J
    Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):34-41. PubMed ID: 11788458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine, coagulation, platelet function, and thrombosis.
    Coppola A; Davi G; De Stefano V; Mancini FP; Cerbone AM; Di Minno G
    Semin Thromb Hemost; 2000; 26(3):243-54. PubMed ID: 11011842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Contribution of Homocysteine Metabolism Disruption to Endothelial Dysfunction: State-of-the-Art.
    Esse R; Barroso M; Tavares de Almeida I; Castro R
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.